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Abstract
Although Lrp5 is known to be an important contributor to the mechanisms regulating bone mass, its precise role remains
unclear. The aim of this study was to establish whether mutations in Lrp5 are associated with differences in the growth and/
or apoptosis of osteoblast-like cells and their proliferative response to mechanical strain in vitro. Primary osteoblast-like cells
were derived from cortical bone of adult mice lacking functional Lrp5 (Lrp5
2/2), those heterozygous for the human G171V
High Bone Mass (HBM) mutation (LRP5
G171V) and their WT littermates (WTLrp5,W T HBM). Osteoblast proliferation over time
was significantly higher in cultures of cells from LRP5
G171V mice compared to their WTHBM littermates, and lower in Lrp5
2/2
cells. Cells from female LRP5
G171V mice grew more rapidly than those from males, whereas cells from female Lrp5
2/2 mice
grew more slowly than those from males. Apoptosis induced by serum withdrawal was significantly higher in cultures from
Lrp5
2/2 mice than in those from WTHBM or LRP5
G171V mice. Exposure to a single short period of dynamic mechanical strain
was associated with a significant increase in cell number but this response was unaffected by genotype which also did not
change the ‘threshold’ at which cells responded to strain. In conclusion, the data presented here suggest that Lrp5 loss and
gain of function mutations result in cell-autonomous alterations in osteoblast proliferation and apoptosis but do not alter
the proliferative response of osteoblasts to mechanical strain in vitro.
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Introduction
Normal bone homeostasis is achieved by balancing the number
and activity of bone forming osteoblasts and bone resorbing
osteoclasts. In the adult skeleton the mechanical strain engendered
within the bone tissue by the activities of normal life acts as
a stimulus to regulate this osteoblast/osteoclast balance, thereby
controlling bone mass and architecture such that the skeleton is of
sufficient strength to withstand the loads placed upon it without
damage. There is compelling evidence that the co-ordinated
activities of many different signalling pathways function to control
osteoblast number and activity both basally and in response to
mechanical strain [1]. One such pathway is the Wnt pathway.
Engagement of the Wnt ligand with the receptor complex
comprising of Frizzled and Lrp5/6 stimulates activation of the
canonical (involving b-catenin activation) and planar cell polarity
pathways. Indeed Wnt signalling has been implicated in the
regulation of mesenchymal precursor commitment to the osteo-
blast lineage [2,3], osteoblast proliferation [4,5], terminal
differentiation [6] and apoptosis [7–9]. Humans with an
inactivating mutation in the Lrp5 Wnt co-receptor gene have
reduced bone mass [6,10,11], whilst individuals with an activating
mutation (the G171V mutation) have correspondingly higher than
normal bone mass [12–14]. Experimental models such as Lrp5
knockout mice [4] or mice expressing human LRP5 transgene
containing the G171V activating mutation (LRP5
G171V) [7]
generally recapitulate the situation in humans and have low and
high bone mass respectively.
Sawakami et al., (2006) provided in vivo evidence that the Wnt
pathway may play a role in mediating bone’s adaptive response to
loading, by demonstrating that mice lacking functional LRP5 have
an impaired cortical bone response to ulna loading [15]. In
a recent study that analysed multiple bone responses to graded
strains we also demonstrated that absence of Lrp5 activity due to
the Lrp5
2/2 mutation reduces the osteogenic effects of loading in
male (but not female) mice, whilst the presence of the LRP5
G171V
mutated gene was associated with increased mechano-responsive-
ness [16]. However, this study supported only a limited gender-
related role for LRP5 function in mediating bone’s adaptive
response to mechanical loading in vivo.
Given that Lrp5 status in vivo impacts basal and mechanically
influenced bone mass, we sought to investigate in vitro whether
primary long-bone-derived osteoblast like cells derived from both
the Lrp5
2/2 or LRP5
G171V mice displayed cell autonomous
differences in their basal growth and apoptosis rates that could
explain these physiological phenotypes. We also measured
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e35726proliferation in these cells following exposure to mechanical strain
in order to determine whether Lrp5 functionality regulated the
magnitude of the strain-related response and/or altered the
‘threshold’ at which a proliferative response to strain was
engendered.
Materials and Methods
Ethics statement
The genetic background of LRP5
G171V and Lrp5
2/2 is the
mouse strain C57BL/6 (Charles River Laboratories, Margate,
Kent, U.K). LRP5
G171V transgenic and Lrp5
2/2 mice were a gift
from Babij et al., (2003) and Kato et al., (2002) respectively [4,7].
Mice from both colonies were housed up to 5 per cage in
polypropylene cages with wood chip and paper bedding and
provided standard mouse chow and water ad libitum. Weaners up
to 8 weeks of age were fed a standard rodent breeding diet and
thereafter a standard rodent maintenance diet (Special Diet
Services, South Witham, UK). All of the procedures conducted in
the facility were carried out in accordance with the UK Animals
Act (Scientific Procedures) 1986 under a UK Government Home
Office project license number PIL70/6350, reviewed and
approved by the Royal Veterinary College Local Ethical Review
Committee (London, UK).
Cell extraction
At 19 weeks of age, LRP5
G171V and Lrp5
2/2 mice and their
WT littermates (WTHBM and WTLrp5) were euthanized by means
of cervical dislocation. Primary osteoblast-like cells were isolated
from femur, radii, ulnae and humerus as described previously [17].
The osteoblast-like cells were maintained in Dulbecco’s minimal
essential medium (DMEM) without phenol-red, 2 mM L-gluta-
mine (Life Technologies Ltd.), 100 U/ml penicillin (Life Tech-
nologies Ltd.), and 100 mg/ml streptomycin (Invitrogen Ltd,
Paisley, Scotland, UK (Life Technologies Ltd.) supplemented with
10% heat-inactivated foetal calf serum (FCS) (LabTech In-
ternational, East Sussex, UK) and were incubated at 37uCi n
a humidified 5% CO2 incubator. Only first passage cells (P1) were
used.
Cell proliferation rates
Primary osteoblast-like cells isolated from female and male
LRP5
G171V and Lrp5
2/2 mice and their WT littermates and
experiments were repeated three times (2 mice of each gender and
genotype were used). The cells were seeded evenly onto custom-
made sterile, tissue culture-treated plastic strips (66 mm622 mm)
(Nunc, Dossel, Germany) at a density of 100,000 cells/strip. Four
strips were incubated together in quadriPERM 4-well plates
(Greiner Bio-One, Stonehouse, UK) in DMEM supplemented
with 10% FCS. Cells were fixed for 10 minutes in absolute ice-
cold MeOH (VWR International) 2, 4, 6 and 8 days after seeding
followed by one wash with PBS. To quantify cell number, cells
were stained with propidium iodide (INCYTO, Seoul, South
Korea) and counted using a Microchip Type Automatic Cell
Counter according to the manufacturer’s instructions (INCYTO,
Seoul, South Korea).
TUNEL staining
For each experiment and each experimental group, primary
osteoblast-like cells were extracted from the femur, humerus,
radius and ulna of one 19 week old mouse. These studies were
repeated 3 times and thus included 3 mice per group. 20,000 first
passage primary osteoblast-like cells derived from female and male
Lrp5
2/2, LRP5
G171V and WTHBM mice were seeded onto 24-
multiwell plates (16 mm in diameter) and cultured in DMEM
supplemented with 10% FCS. Six wells per treatment group were
used. After 72 hours the cells were washed twice with serum free
DMEM and thereafter were incubated with fresh DMEM
containing 0.1%, 2.5% or 10% FCS. After 48 hours the cells
were fixed with 4% paraformaldehyde. Nuclear DNA fragmen-
tation as a measure of apoptosis was evaluated by the terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labelling
(TUNEL) method using DeadEnd Fluorometric TUNEL System
(Promega, Madison, WI) according to the manufacturer’s pro-
tocol. Vectashield mounting medium with DAPI (Vector Labora-
tories) was used for the counterstaining of nuclei. Nuclear TUNEL
positive cells were judged to be apoptotic. Total cell number and
the percentage of TUNEL positive cells were determined in 5
microscopic fields per well at 106magnification. The fields were
photographed using a Leica Q550IW fluorescent microscope with
a DC 500 Leica digital camera and cells were counted from the
computer screen with the assistance of the Leica Qwin computer
programme (Leica, Solms, Germany).
Cell proliferation in response to mechanical strain
Primary osteoblast-like cells isolated from female and male
LRP5
G171V and Lrp5
2/2 mice and their WT littermates were
seeded onto custom-made sterile, tissue culture-treated plastic
strips (Nunc, Dossel, Germany) at a density of 100,000 cells/strip
(3 mice of each gender and genotype were used and experiments
were repeated three times). Four strips were used per condition
and were incubated together in quadriPERM 4-well plates
(Greiner Bio-One, Stonehouse, UK) maintained in DMEM
containing 10% FCS for 5 days. Mechanical strain was applied
using a loading jig that applies four-point bending to each strip
with minimal fluid perturbation as described previously [17]. Cells
were subjected to a single period of 600 cycles of four-point-
bending at a frequency of 1 Hz. This generated a peak strain of
2500, 2900 or 3400 me. Following strain treatment the strips and
media were replaced into the 4-well plates and incubated for
48 hours. Control strips were placed in wells of the loading
apparatus and subjected to similar perturbation of surrounding
media as experienced by the strained strips. However, these strips
were not subjected to bending and thus the cells that were plated
onto them were not subjected to strain. Cells were stained with
propidium iodide (INCYTO, Seoul, South Korea) and counted
using a Microchip Type Automatic Cell Counter according to the
manufacturer’s instructions (INCYTO, Seoul, South Korea).
Statistical Analysis
Statistical significance was determined by a 2-tailed unpaired
Student’s t-test or one way analysis of variance (ANOVA) followed
by the post hoc (Bonferroni) multiple comparisons between
treatment groups using SPSS statistics package version 16 for
Windows (SPSS, Chicago, IL, USA). The mixed model analysis
was performed using SAS system v9.0 (SAS Institute, Cary, NC,
USA). Cell doubling time were calculated using GraphPad Prism
v5.0 software for Windows (GraphPad Software Inc., San Diego,
CA) by nonlinear regression (exponential growth equation)
analysis. Least significant difference was determined and p,0.05
considered statistically significant. Data displayed as mean 6
SEM.
Results
Osteoblast proliferation over time in vitro
Primary osteoblast-like cells extracted from the long bones of
female and male LRP5
G171V and Lrp5
2/2 mice and their WT
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a main effect of genotype (p,0.001) and time in culture on cell
number (p,0.001). The post-hoc analysis showed that cells from
LRP5
G171V mice proliferated faster than cells from the WTHBM
littermates (p,0.001), whereas cells from Lrp5
2/2 mice pro-
liferated more slowly than cells from WTLrp5 littermates. A gender
and genotype interaction was detected (p,0.001) together with
interaction between gender, genotype and time (p,0.001). The
post-hoc analysis also showed that cells from female LRP5
G171V
mice grew faster than cells from male LRP5
G171V, male and female
WTHBM and male and female Lrp5
2/2 mice (p,0.001).
Furthermore, female Lrp5
2/2 cells proliferated more slowly
compared to male Lrp5
2/2 cells (p,0.001). Doubling time
calculated from the regression analysis of each genotype is shown
in table 1.
TUNEL staining of cells exposed to serum depletion
Having observed that cells from different genotypes of mice
proliferated at different rates, we sought to establish whether this
reflected a difference in the rate of apoptosis. Significantly higher
levels of TUNEL stained cells were observed in cultures from
Lrp5
2/2 mice compared to cultures from WTHBM and LRP5
G171V
mice (p,0.001) (Fig. 2). In contrast, the percentage of TUNEL
stained cells from LRP5
G171V mice was significantly lower
compared to Lrp5
2/2 and WTHBM cells (p,0.001). There was
an effect of gender, genotype and serum concentration on
percentage of TUNEL stained cells (p,0.001) and an interaction
between genotype and serum concentration was also detected
(p,0.001). In 0.1 and 2.5% serum the percentage of TUNEL
positive osteoblast-like cells was significantly higher in cultures of
female and male Lrp5
2/2 mice compared to cultures of female
and male WTHBM and LRP5
G171V cells (p,0.001 and p,0.01
respectively). Similar to the situation in 0.1 and 2.5% serum, the
percentage of TUNEL positive cells in 10% serum was
significantly higher in cultures of female and male Lrp5
2/2 cells
compared to female and male WTHBM and LRP5
G171V cells
(p,0.05). Gender related differences in the percentage of TUNEL
positive cells were also observed within each genotype; in 2.5%
and 10% serum the percentage of TUNEL positive cells was
higher in cultures of male WTHBM cells compared to cultures of
female WTHBM cells (p,0.05) and no gender differences in
TUNEL positive cells was observed in 0.1% serum. In contrast, in
2.5% serum the percentage of TUNEL positive cells was higher in
cultures of female Lrp5
2/2 cells compared to cultures of male
Lrp5
2/2 cells (p,0.01) and no gender differences in 0.1% and
10% was observed.
Figure 1. Proliferation of primary osteoblast-like cells derived from female and male LRP5
G171V and Lrp5
2/2 mice and their WT
littermates. Osteoblast-like cells were cultured over 8 days and were fixed in absolute ice-cold MeOH on day 2, 4, 6 and 8. Cell’s nuclei were stained
using propidium iodide and counted using Microchip Type Automatic Cell Counter machine. Results are the mean 6 SEM of three independent
experiments. N=4. Groups with the same letter are not significantly different. b vs. a = P,0.001. a + b vs. c = P,0.001.
doi:10.1371/journal.pone.0035726.g001
Table 1. Cell population doubling time of primary osteoblast-
like cells derived from female and male Lrp5
2/2, LRP5
G171V
and their WT littermates.
Genotype Double time (days)
Female WTHBM 3.42
Male WTHBM 3.26
Female WTLrp5 3.26
Male WTLrp5 3.36
Female LRP5
G171V 2.52
Male LRP5
G171V 2.96
Female Lrp5
2/2 24.34
Male Lrp5
2/2 4.14
Doubling time in days between 2 and 8 days of culture of primary osteoblast-
like cells isolated from female and male Lrp5
2/2, LRP5
G171V and their WT
littermates. Cell doubling time were calculated using GraphPad Prism v5.0
software for Windows (GraphPad Software Inc., San Diego, CA) by nonlinear
regression (exponential growth equation) analysis.
doi:10.1371/journal.pone.0035726.t001
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in vitro
The proliferative response of osteoblast-like cells cultured from
each gender and genotype of mice to different magnitudes of
mechanical strain is shown in figure 3. All groups showed no
response at 2,500 me and 2,900 me however, for each gender and
genotype (p,0.001) a significant increase in cell number was
detected at 3,400 me (Figs. 3A, B and C). We also calculated the
percentage increase in cell number between the control (static) and
strained groups and found no significant differences between
female and male or LRP5
G171V, Lrp5
2/2 and WT cells (Fig. 3D).
Mixed model analysis showed a main effect of gender
(p,0.001), genotype (p,0.001) and strain (p,0.001) on cell
number. A genotype and strain interaction was detected (p,0.006)
and an interaction between gender, genotype and strain
(p,0.001). As described previously, the number of cells in static
control cultures of female and male LRP5
G171V cells was
significantly higher than in Lrp5
2/2 and WTHBM cultures. This
reflects significant differences in basal proliferation between
LRP5
G171V, Lrp5
2/2 and WT cells (Fig. 1).
Discussion
LRP5 plays a role in osteoblast proliferation
The key finding from this study was that absence of Lrp5
function in osteoblastic cells derived from the cortical bone of adult
mice was associated with decreased proliferation as evidenced by
an increase in cell population doubling time compared with
WTLrp5 cells in vitro. Conversely, presence of the LRP5
G171V
mutation in osteoblastic cells was associated with increased
proliferation compared with Lrp5
2/2 and WT cells. Cell
Figure 2. Percentage of apoptosis in osteoblast-like cells
48 hours after treatment with 0.1% (A), 2.5% (B) and 10% (C)
serum. The TUNEL staining was used to determine the percentage of
apoptotic cells in primary osteoblast-like cells derived from male and
female WTHBM, Lrp5
2/2 and LRP5
G171V mice. Results are mean 6 SEM of
three independent experiments. Groups with the same letter are not
significantly different.
doi:10.1371/journal.pone.0035726.g002
Figure 3. Effects of 2500, 2900 and 3400 me on proliferation of
primary osteoblast-like cells derived from female and male WT
(A), Lrp5
2/2 (B) and LRP5
G171V (C) mice. Changes in absolute
number of cells between static and strain of both genotypes and
genders are shown. Results are mean 6 SEM of three independent
experiments. Experiments were repeated 3 times. No significant
differences at 2500 and 2900 me were observed. ***p,0.001 and
*p,0.05 compared with the static control within the gender. (D) The
effects of 3400 me on proliferation of primary osteoblast-like cells
derived from female and male LRP5
G171V and Lrp5
2/2 mice and their WT
littermates. Percentage differences between static and strain of both
genotypes and genders are shown. Results are the mean 6 SEM of
three independent experiments. Experiments were repeated 3 times.
There were no significant differences between groups.
doi:10.1371/journal.pone.0035726.g003
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female and male WTHBM and WTLrp5 cells, suggesting that WT
cells from both backgrounds have a similar proliferation rate.
These findings provide evidence that the presence of functional
LRP5 protein plays an important role in the regulation of
osteoblast proliferation, which is in broad agreement with previous
studies [4,6].
These results are not consistent with those of Yadav et al., (2009)
who observed no significant differences between the proliferation
of Lrp5
2/2 and WTLrp5 osteoblast-like cells [18]. However,
differences between our two studies could potentially explain
these apparently contrasting observations. The first relates to the
site of origin of the cells; the study described here used osteoblast-
like cells derived from long bones, whereas Yadav et al, (2009) used
calvarial derived osteoblast-like cells. Several years ago our group
demonstrated that osteoblastic cells from long bones and calvariae
respond differently to a strain-related stimulus [19]. More recently
another study confirmed that primary osteoblast-like cells derived
from calvariae or long bones are both phenotypically different in
vitro and also are significantly different at the level of gene
expression [20]. Second, the age of animals was very different in
the two studies; Yadav et al (2009) derived osteoblast-like cells from
new born mice whereas cells from adult (19 week old) mice were
used in the present study. Because pre-osteoblasts and osteoblasts
from young humans and animals proliferate more rapidly than
cells from older animals [21–29], this potentially could ‘mask’ the
effect on proliferation of the loss of Lrp5. It must also be considered
that the long-term loss of Lrp5 (from birth to 19 weeks of age) has
different effects to loss of the gene during development only. Kato
et al., (2002) demonstrated that bone formation was normal in
Lrp5
2/2 mice at 17.5 days post coitum and at birth there was only
a subtle delay in osteogenesis. However, the ossification defect in
these mice became more pronounced with age and reflected
a defect in osteoblast proliferation. Finally, different promoters
were used in the two studies. The LRP5
G171V mice used for the
present study were generated by Babij et al. (2003) using the 3.6 kb
fragment of the collagen type 1 promoter to drive the expression of
the transgene in pre-osteoblasts and osteoblasts, with minimal to
no expression in other cell types [30,31]. In contrast, Yadav et al.,
(2009) used the 2.3 kb collagen type I promoter –cre to replace
one copy of the endogenous murine Lrp5 gene with one copy of
Lrp5 carrying the high bone mass G171V mutation. This
generated mice with one WT and one G171V allele, rather than
two WT and one G171V allele as used here. The 2.3 kb promoter
driving Cre expression is activated later in the osteoblast
differentiation pathway than the 3.6 kb promoter, and is thus
active in more mature osteoblasts [30].
We have also found that the effect of Lrp5 mutations on
osteoblast proliferation was more pronounced in cells from female
mice, such that Lrp5 gain of function stimulated whilst Lrp5 loss of
function impaired proliferation. We have previously shown that
ERa is required for b-catenin function in response to strain and it
is now apparent that this is mediated, at least in part, by the non-
genomic signalling effects of ER involved with IGFIR’s action
[32,33]. This suggests that there are gender differences in LRP5-b-
catenin signalling in osteoblasts, with females being more affected
by changes in its activity because of potential interactions with the
E2/ERa IGF-I signalling pathways. Interestingly, it has been
shown that bone marrow stromal cells isolated from young women
express higher levels of the ER and the ERR target gene Wnt11.
Conversely, male BMSCs express higher levels of Wnt 16, which
has two isoforms associated with either senescence or proliferation
[34,35].
LRP5 is involved in osteoblast apoptosis
Having demonstrated differences in proliferation of cells from
different genotypes, we studied the effect of LRP5 mutations on
TUNEL staining which showed that loss of LRP5 function
increased apoptosis in primary osteoblast-like cells from Lrp5
2/2
mice. This result suggest that the low bone mass phenotype
observed in vivo may reflect, at least in part, high levels of apoptosis
in the bone cells of these mice. This finding is in agreement with
a previous in vitro study in which apoptosis in calvarial-derived
osteoblast-like cells from Lrp5
2/2 mice was shown to be higher
compared to WT cells [9]. However, our data is not in agreement
with a previous in vivo study by Kato et al., (2002), in which no
difference in osteoblast apoptosis rates were observed in calvarial
sections from Lrp5
2/2 mice. The LRP5 G171V mutation seems to
provide some protection against apoptosis induced by serum
depletion however, the effect of this mutation on osteoblast
apoptosis does not appear to be as significant as the loss of LRP5
function. Notwithstanding, our findings support the idea that
LRP5 is a critical component in the regulation of bone cell
apoptosis [7–9,36,37].
LRP5 is not required for the proliferative response of
osteoblasts to strain
One of the effects of mechanical strain is to stimulate
proliferation of cells that are, or will become, osteoblasts [38–
47]. In the studies reported here neither absence of LRP5 function
nor the presence of the LRP5
G171V mutation altered the
proliferative response of cortical derived primary osteoblast-like
cells to mechanical strain in vitro. These data are in agreement with
two recent in vitro studies which suggested that the strain-induced
activation of b-catenin does not require LRP5 [33,48,49], although
a previous in vivo study had shown that the loading response was
abolished in mice lacking LRP5 [15].
Neither did the Lrp5
2/2 or the LRP5
G171V mutation alter the
‘minimum effective strain’ at which strain engendered a pro-
liferative response, thus our findings are not consistent with in vivo
evidence that a lower strain threshold is sufficient to induce
cortical bone formation in LRP5
G171V mice [50,51]. We have also
recently demonstrated that the increased load-induced osteogen-
esis in the cortical and cancellous bone of mice with the
LRP5
G171V mutation is more pronounced in females than males
[16]. One possible explanation for the apparent differences
between our in vitro data and in vivo findings is that LRP5
mutations may alter the strain responsiveness in osteocytes rather
than osteoblasts. For example, differences in responses to fluid flow
shear stress have been reported in osteocytes versus osteoblasts
[49,52,53]. Our in vitro model includes osteoblasts with little or no
osteocytic component and so does not replicate the complex
context of cortical bone.
In conclusion, we have provided data to demonstrate that in
cortical bone-derived primary osteoblast-like cells from adult mice,
LRP5 is an integral component of the signalling pathways that
regulate cell proliferation and apoptosis. However, it is not
required for the proliferative response of these cells to mechanical
strain. The intrinsically higher rate of proliferation and reduced
apoptosis observed in the LRP5
G171V osteoblastic cells may result
in an increased amount of new bone being formed which would
partially explain the high bone mass seen in individuals with this
mutation.
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